Linden Advisors’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-38,994
Closed -$389K 1012
2021
Q1
$389K Buy
+38,994
New +$399K ﹤0.01% 597

Other funds holding HCAQ

Linden Advisors's HCAQ Position: Q2 2021 in Review

Linden Advisors sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q2 2021, closing a stake of 38,994 shares — an estimated $389K sold.

Linden Advisors first reported a position in HCAQ in Q1 2021 and held it in 1 quarter. The position peaked at $389K in Q1 2021. 77 funds tracked by Wall St. Rank hold HCAQ as of Q2 2021.

  • Linden Advisors reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Linden Advisors sold 38,994 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q2 2021, an estimated $389K.
  • Linden Advisors first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 1 quarter.
  • Linden Advisors's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $389K in Q1 2021.
  • 77 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q2 2021.

Based on Linden Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.